Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis

Infection and Immunity

Volumn 73, Issue 7, 2005, Pages 3888-3895

  Mullarky, Isis K ^a   Szaba, Frank M ^a   Berggren, Kiera N ^a   Parent, Michelle A ^a   Kummer, Lawrence W ^a   Chen, Wangxue ^b   Johnson, Lawrence L ^a   Smiley, Stephen T ^a  

^a TRUDEAU INSTITUTE   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRIN; FIBRINOGEN; WARFARIN;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL INFECTION; BLEEDING; BLOOD CLOTTING; CLEARANCE; CONTROLLED STUDY; DISEASE EXACERBATION; GRAM POSITIVE BACTERIUM; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; MORTALITY; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ANIMALS; FIBRIN; HEMORRHAGE; INTERFERON TYPE II; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21544436571     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.7.3888-3895.2005     Document Type: Article

References (46)

1. Ahrenholz, D. H., and R. L. Simmons. 1980. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery 88:41-47.
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-1310.
3. Anonymous. 1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
4. Bernard, G. R., J. L. Vincent, P. F. Laterre, S. P. LaRosa, J. F. Dhainaut, A. Lopez-Rodriguez, J. S. Steingrub, G. E. Garber, J. D. Helterbrand, E. W. Ely, and C. J. Fisher, Jr. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
5. Boyle, M. D., and R. Lottenberg. 1997. Plasminogen activation by invasive human pathogens. Thromb. Haemostasis 77:1-10.
6. Ciano, P. S., R. B. Colvin, A. M. Dvorak, J. McDonagh, and H. F. Dvorak. 1986. Macrophage migration in fibrin gel matrices. Lab. Investig. 54:62-70.
7. Coleman, J. L., J. A. Gebbia, J. Piesman, J. L. Degen, T. H. Bugge, and J. L. Benach. 1997. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89:1111-1119.
8. Conlan, J. W., and R. J. North. 1991. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J. Exp. Med. 174:741-744.
9. Conlan, J. W., and R. J. North. 1994. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179:259-268.
10. Czuprynski, C. J., J. F. Brown, N. Maroushek, R. D. Wagner, and H. Steinberg. 1994. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152:1836-1846.
11. Czuprynski, C. J., J. F. Brown, R. D. Wagner, and H. Steinberg. 1994. Administration of antigranulocyte monoclonal antibody RB6-8C5 prevents expression of acquired resistance to Listeria monocytogenes infection in previously immunized mice. Infect. Immun. 62:5161-5163.
12. Davies, W. A., V. P. Ackerman, and D. S. Nelson. 1981. Mechanism for nonspecific immunity of Listeria monocytogenes in rats mediated by platelets and the clotting system. Infect. Immun. 33:477-481.
13. Dempfle, C. E. 2004. Coagulopathy of sepsis. Thromb. Haemostasis 91:213-224.
14. Dhainaut, J. F., S. B. Yan, B. D. Margolis, J. A. Lorente, J. A. Russell, R. C. Freebairn, H. D. Spapen, H. Riess, B. Basson, G. Johnson III, and G. T. Kinasewitz. 2003. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis. Thromb. Haemostasis 90:642-653.
15. Doganay, M. 2003. Listeriosis: clinical presentation. FEMS Immunol. Med. Microbiol. 35:173-175.
16. Dubrow, T., R. J. Schwartz, J. McKissock, and S. E. Wilson. 1991. Effect of aerosolized fibrin solution on intraperitoneal contamination. Arch. Surg. 126:80-83.
17. Dunn, D. L., and R. L. Simmons. 1982. Fibrin in peritonitis. III. The mechanism of bacterial trapping by polymerizing fibrin. Surgery 92:513-519.
18. Echtenacher, B., K. Weigl, N. Lehn, and D. N. Mannel. 2001. Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect. Immun. 69:3550-3555.
19. Flick, M. J., X. Du, D. P. Witte, M. Jirouskova, D. A. Soloviev, S. J. Busuttil, E. F. Plow, and J. L. Degen. 2004. Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo. J. Clin. Investig. 113:1596-1606.
20. Foster, T. J., and M. Hook. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6:484-488.
21. Gebbia, J. A., J. C. Monco, J. L. Degen, T. H. Bugge, and J. L. Benach. 1999. The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J. Clin. Investig. 103:81-87.
22. Gregory, S. H., A. J. Sagnimeni, and E. J. Wing. 1996. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J. Immunol. 157:2514-2520.
23. Hoffmann-Fezer, G., H. Maschke, H. J. Zeitler, P. Gais, W. Heger, J. Ellwart, and S. Thierfelder. 1991. Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies. Ann. Hematol. 63:214-217.
24. Hudspeth, A. S. 1975. Radical surgical debridement in the treatment of advanced generalized bacterial peritonitis. Arch. Surg. 110:1233-1236.
25. Johnson, L. L., K. N. Berggren, F. M. Szaba, W. Chen, and S. T. Smiley. 2003. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197:801-806.
26. Kerlin, B. A., S. B. Yan, B. H. Isermann, J. T. Brandt, R. Sood, B. R. Basson, D. E. Joyce, H. Weiler, and J. F. Dhainaut. 2003. Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102:3085-3092.
27. Kinasewitz, G. T., S. B. Yan, B. Basson, P. Comp, J. A. Russell, A. Cariou, S. L. Um, B. Utterback, P. F. Laterre, and J. F. Dhainaut. 2004. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit. Care 8:R82-R90.
28. LaCourse, R., L. Ryan, and R. J. North. 2002. Expression of NADPH oxidase-dependent resistance to listeriosis in mice occurs during the first 6 to 12 hours of liver infection. Infect. Immun. 70:7179-7181.
29. Lara-Tejero, M., and E. G. Pamer. 2004. T cell responses to Listeria monocytogenes. Curr. Opin. Microbiol. 7:45-50.
30. Levi, M., E. de Jonge, and T. van der Poll. 2004. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann. Med. 36:41-49.
31. Mackaness, G. B. 1962. Cellular resistance to infection. J. Exp. Med. 116: 381-406.
32. Mackaness, G. B. 1969. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129:973-992.
33. McRitchie, D. I., M. J. Girotti, M. F. Glynn, J. M. Goldberg, and O. D. Rotstein. 1991. Effect of systemic fibrinogen depletion on intraabdominal abscess formation. J. Lab. Clin. Med. 118:48-55.
34. Muntean, V. E. 1987. Fibrin in peritonitis. Ann. Surg. 206:681-682.
35. North, R. J., P. L. Dunn, and J. W. Conlan. 1997. Murine listeriosis as a model of antimicrobial defense. Immunol. Rev. 158:27-36.
36. Rakhmilevich, A. L. 1995. Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes. J. Leukoc. Biol. 57:827-831.
37. Rogers, H. W., and E. R. Unanue. 1993. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immun. 61:5090-5096.
38. Rothfork, J. M., S. Dessus-Babus, W. J. Van Wamel, A. L. Cheung, and H. D. Gresham. 2003. Fibrinogen depletion attenuates Staphylococcus aureus infection by preventing density-dependent virulence gene up-regulation. J. Immunol. 171:5389-5395.
39. Rotstein, O. D. 1992. Role of fibrin deposition in the pathogenesis of intra-abdominal infection. Eur. J. Clin. Microbiol. Infect. Dis. 11:1064-1068.
40. Rotstein, O. D., and J. Kao. 1988. Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. J. Infect. Dis. 158:766-772.
41. Sun, T. T., K. Holmback, N. J. Jensen, C. C. Daugherty, K. Small, D. I. Simon, S. Potter, and J. L. Degen. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9:2020-2033.
42. Sun, H., U. Ringdahl, J. W. Homeister, W. P. Fay, N. C. Engleberg, A. Y. Yang, L. S. Rozek, X. Wang, U. Sjobring, and D. Ginsburg. 2004. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305:1283-1286.
43. Szaba, F. M., and S. T. Smiley. 2002. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99:1053-1059.
44. Van Hove, L., W. Goossens, V. Van Duppen, and R. L. Verwilghen. 1990. Reticulocyte count using thiazole orange. A flow cytometry method. Clin. Lab. Haematol. 12:287-299.
45. Wing, E. J., and S. H. Gregory. 2002. Listeria monocytogenes: clinical and experimental update. J. Infect. Dis. 185(Suppl. 1):S18-S24.
46. Zinsser, H. H., and A. W. Pryde. 1952. Experimental study of physical factors, including fibrin formation, influencing the spread of fluids and small particles within and from the peritoneal cavity of the dog. Ann. Surg. 136:818-827.